JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

Home・Akciju saraksts・iRhythm Technologies Inc

iRhythm Technologies Inc

Slēgts

SektorsVeselības aprūpe

146.48 -0.08

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

145.76

Max

148.6

Galvenie mērījumi
By Trading Economics
Ienākumi	9M -5.2M
Pārdošana	6.2M 193M
Peļņas marža	-2.702
Darbinieki	2,000
EBITDA	7.7M 2.4M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+50.53% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 19. febr.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-853M 5B
Iepriekšējā atvēršanas cena	146.56
Iepriekšējā slēgšanas cena	146.48

Ziņu noskaņojums

By Acuity

50%

151 / 352 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Bullish Evidence

104.78 / 137.91 Atbalsts un pretestība

iRhythm Technologies Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 6. febr. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 6. febr. 21:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 6. febr. 21:40 UTC

Iegādes, apvienošanās, pārņemšana

Verizon Insiders Rarely Sell Company Stock. This Insider Just Did. -- Barrons.com

2026. g. 6. febr. 21:22 UTC

Tirgus saruna

Mexico's Inflation Seen Accelerating in January -- Market Talk

2026. g. 6. febr. 21:17 UTC

Peļņas

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

2026. g. 6. febr. 21:15 UTC

Tirgus saruna

Global Commodities Roundup: Market Talk

2026. g. 6. febr. 21:14 UTC

Iegādes, apvienošanās, pārņemšana

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- Update

2026. g. 6. febr. 21:13 UTC

Peļņas

How the Software Panic Hit BDC Stocks -- and Why Some Might Be Worth Buying -- Barrons.com

2026. g. 6. febr. 21:13 UTC

Peļņas

Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers -- Barrons.com

2026. g. 6. febr. 21:04 UTC

Tirgus saruna

Gold Closes Out Volatile Week on Higher Note -- Market Talk

2026. g. 6. febr. 20:34 UTC

Peļņas

Tech Had an Awful Earnings Season. Other Stocks Are Saving the Day. -- Barrons.com

2026. g. 6. febr. 20:27 UTC

Peļņas

These Stocks Are Today's Movers: Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More -- Barrons.com

2026. g. 6. febr. 20:24 UTC

Tirgus saruna

Oil Futures Settle Higher As U.S.-Iran Talks Get Under Way -- Market Talk

2026. g. 6. febr. 20:20 UTC

Tirgus saruna

U.S. Natural Gas Futures Retreat Ahead of Weekend -- Market Talk

2026. g. 6. febr. 19:48 UTC

Peļņas

Take-Two, Mondelez Get Analyst Attention -- Barrons.com

2026. g. 6. febr. 19:30 UTC

Iegādes, apvienošanās, pārņemšana

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- WSJ

2026. g. 6. febr. 19:30 UTC

Iegādes, apvienošanās, pārņemšana

Justice Department Asking Industry How Netflix or Paramount Deal for Warner Bros. Might Impact Competition, According to Subpoena -- WSJ

2026. g. 6. febr. 19:30 UTC

Iegādes, apvienošanās, pārņemšana

DOJ Asking if Netflix Engaged in 'Exclusionary Conduct' That May Lead to Monopoly, According to Subpoena -- WSJ

2026. g. 6. febr. 19:17 UTC

Tirgus saruna

USDA Says Farm Income to Decrease in 2026 -- Market Talk

2026. g. 6. febr. 18:50 UTC

Peļņas

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

2026. g. 6. febr. 18:47 UTC

Tirgus saruna

Natural Gas-Infrastructure Operators Take 'Flight to Scale' -- Market Talk

2026. g. 6. febr. 18:34 UTC

Tirgus saruna

U.S. Oil Rig Count Rises By 1 to 412 -- Market Talk

2026. g. 6. febr. 17:58 UTC

Peļņas

Reddit Stock Falls After Strong Earnings. Wall Street Is Debating What's Next. -- Barrons.com

2026. g. 6. febr. 17:52 UTC

Tirgus saruna

Peļņas

Global Equities Roundup: Market Talk

2026. g. 6. febr. 17:52 UTC

Tirgus saruna

Peļņas

Amazon's CapEx Seen as Misunderstood by Investors -- Market Talk

2026. g. 6. febr. 17:20 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2026. g. 6. febr. 17:20 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 6. febr. 17:20 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 6. febr. 17:18 UTC

Tirgus saruna

Canada's Bizarre Jobs Report Points to Growing Labor Slack -- Market Talk

2026. g. 6. febr. 17:09 UTC

Tirgus saruna

Dollar on Path to Snap Weekly Losing Streak -- Market Talk

Salīdzinājums

Cenas izmaiņa

iRhythm Technologies Inc Prognoze

Cenas mērķis

By TipRanks

50.53% augšup

Prognoze 12 mēnešiem

Vidējais 220.9 USD 50.53%

Augstākais 244 USD

Zemākais 205 USD

Pamatojoties uz 12 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi iRhythm Technologies Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

12 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 12 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam iRhythm Technologies Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

104.78 / 137.91Atbalsts un pretestība

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bullish.

Noskaņojums

By Acuity

151 / 352 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par iRhythm Technologies Inc

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.